Danaher (NYSE:DHR) will post its quarterly earnings results before the market opens on Thursday, April 18th. Analysts expect Danaher to post earnings of $1.01 per share for the quarter. Individual interested in participating in the company’s earnings conference call can do so using this link.
Danaher (NYSE:DHR) last issued its quarterly earnings data on Tuesday, January 29th. The conglomerate reported $1.28 earnings per share for the quarter, beating analysts’ consensus estimates of $1.27 by $0.01. Danaher had a net margin of 13.33% and a return on equity of 11.64%. The business had revenue of $5.40 billion for the quarter, compared to analysts’ expectations of $5.33 billion. During the same period in the previous year, the business earned $1.19 earnings per share. The company’s revenue was up 6.2% on a year-over-year basis. On average, analysts expect Danaher to post $5 EPS for the current fiscal year and $5 EPS for the next fiscal year.
Shares of NYSE DHR opened at $128.18 on Wednesday. Danaher has a fifty-two week low of $94.59 and a fifty-two week high of $134.50. The company has a current ratio of 1.47, a quick ratio of 1.07 and a debt-to-equity ratio of 0.34. The stock has a market cap of $93.40 billion, a P/E ratio of 28.36, a P/E/G ratio of 2.41 and a beta of 1.04.
In related news, Director Walter G. Lohr sold 10,578 shares of Danaher stock in a transaction dated Wednesday, February 27th. The stock was sold at an average price of $126.85, for a total value of $1,341,819.30. Following the transaction, the director now owns 20,691 shares of the company’s stock, valued at approximately $2,624,653.35. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Angela S. Lalor sold 4,534 shares of Danaher stock in a transaction dated Wednesday, February 27th. The stock was sold at an average price of $127.25, for a total value of $576,951.50. Following the completion of the transaction, the senior vice president now directly owns 21,209 shares in the company, valued at approximately $2,698,845.25. The disclosure for this sale can be found here. Over the last quarter, insiders sold 183,150 shares of company stock worth $23,279,637. 11.40% of the stock is owned by company insiders.
Several equities research analysts have commented on DHR shares. Zacks Investment Research upgraded shares of Danaher from a “hold” rating to a “buy” rating and set a $147.00 price target on the stock in a research report on Tuesday, April 9th. Needham & Company LLC reiterated a “buy” rating and issued a $138.00 price target (up from $114.00) on shares of Danaher in a research report on Thursday, February 28th. Jefferies Financial Group boosted their price target on shares of Danaher to $140.00 and gave the stock a “buy” rating in a research report on Tuesday, February 26th. Deutsche Bank boosted their price target on shares of Danaher to $130.00 and gave the stock a “buy” rating in a research report on Tuesday, February 26th. Finally, UBS Group boosted their price target on shares of Danaher from $125.00 to $144.00 and gave the stock a “buy” rating in a research report on Tuesday, February 26th. One investment analyst has rated the stock with a hold rating and fourteen have issued a buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus target price of $125.46.
ILLEGAL ACTIVITY WARNING: This report was reported by Community Financial News and is the sole property of of Community Financial News. If you are viewing this report on another site, it was stolen and republished in violation of US & international copyright and trademark legislation. The correct version of this report can be accessed at https://www.com-unik.info/2019/04/17/danaher-dhr-set-to-announce-quarterly-earnings-on-thursday.html.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.
Recommended Story: How interest rates affect municipal bond prices
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.